Novartis Japan Sets Up Prevention Committee, Cuts Salaries
This article was originally published in PharmAsia News
Executive Summary
Swiss Novartis Pharma Boss David Epstein commented to reporters in Tokyo on the Diovan scandal recently, admitting that the company lacked an internal monitoring system for clinical trials.